With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017.
Inflection point
Much has happened over the course of the year for the pharma industry, there have been a slew of opportunities through advancements, investments and expansions. Yet, the industry has also experienced challenges and is currently riding the tide of political uncertainty.